Clinical trial Recruiting at 1 site Interventional

Structured robotic gait training with the Trexo walker

Official title: Clinical Impacts of Structured Robotic Gait Training Programs

Run by University of Calgary · NCT07405450 · Data updated 2026-11-12

This study will test whether a structured Trexo robotic gait training program helps people with neuromotor walking impairments (for example children with cerebral palsy or those with traumatic brain injury) improve walking and reach their therapy goals.

Quick facts

Study typeInterventional
SexAll
Enrollment120 (estimated)
SponsorUniversity of Calgary
Academic / other
Locations1 site (Calgary, Alberta)
StatusRecruiting
StartedNovember 1, 2022
Main results expectedMay 2026
Study endsDecember 2026
Registry record updatedFebruary 12, 2026
Trial IDNCT07405450 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are people of any age with neuromotor walking impairments who can physically fit the Trexo device (about 5 ft 6 in or shorter and under ~150 lb), tolerate standing and repetitive gait training, and comply with study assessments and sessions.

Probably not a fit

Patients with contraindications to Trexo use—such as recent lower-extremity immobilization or weight-bearing restrictions, unstable cardiac or other medical conditions limiting activity, painful or symptomatic hypotension when standing, severe contractures that prevent forward movement, or those too large for the device—are unlikely to benefit from this program.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The program enrolls people with neuromotor walking impairments who can fit and tolerate the Trexo robotic gait trainer and asks them to follow a structured, hospital-based training schedule. Participants complete repeated overground gait-training sessions with the Trexo device while researchers track adherence, safety, and progress toward patient, family, and therapist goals. Outcome measures include feasibility (attendance and adherence), functional walking measures, and goal attainment assessed at baseline and after the training period. The study also documents practical barriers to access to inform potential home- or community-based implementation.

Why it matters

Potential benefit: If successful, the program could expand practical access to robotic walking therapy and help participants improve walking function and meet meaningful therapy goals.

How similar studies have gone: Prior small studies of robotic gait trainers have reported functional benefits for some participants, but results vary and broader effectiveness is limited by access and study heterogeneity.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* able to fit into Trexo robotic gait trainer (both leg length and weight); height of \<\~5'6", weight \<150 lbs.)
* able to fulfill training requirements throughout training period
* able to comply with study procedures (assessments, training)
* any age

Exclusion Criteria:

* those with contraindications to training with a robotic gait trainer (ie. medical condition or recent surgery requiring lower extremity immobilization or weight-bearing restriction (ie. fracture, unstable hip subluxation), medical condition requiring a physical activity restriction (ie. unstable arrythmia), pain or symptomatic hypotension while standing, contracture such that the Trexo Robotic Gait Training does not result in forward movement)
* those involved in a potentially confounding intervention (will be discussed case-by-case to determine risk of impacting the study results).

Where it's running

  • Alberta Children's Hospital
    Calgary, Alberta, Canada
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.